Cargando…
The efficacy and stability of an information and communication technology-based centralized monitoring system of adherence to immunosuppressive medication in kidney transplant recipients: study protocol for a randomized controlled trial
BACKGROUND: Immunosuppression non-adherence in kidney transplant recipients (KTRs) not only increases the risk of medical intervention due to acute rejection and graft loss but burdens the socioeconomic system in the form of increased healthcare costs. An aggressive preemptive effort by healthcare p...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644178/ https://www.ncbi.nlm.nih.gov/pubmed/29037222 http://dx.doi.org/10.1186/s13063-017-2221-z |
_version_ | 1783271682934308864 |
---|---|
author | Jung, Hee-Yeon Seong, Sook Jin Choi, Ji-Young Cho, Jang-Hee Park, Sun-Hee Kim, Chan-Duck Yoon, Young-Ran Kim, Hyung-Kee Huh, Seung Yoon, Se-Hee Lee, Jong Soo Kim, Yong-Lim |
author_facet | Jung, Hee-Yeon Seong, Sook Jin Choi, Ji-Young Cho, Jang-Hee Park, Sun-Hee Kim, Chan-Duck Yoon, Young-Ran Kim, Hyung-Kee Huh, Seung Yoon, Se-Hee Lee, Jong Soo Kim, Yong-Lim |
author_sort | Jung, Hee-Yeon |
collection | PubMed |
description | BACKGROUND: Immunosuppression non-adherence in kidney transplant recipients (KTRs) not only increases the risk of medical intervention due to acute rejection and graft loss but burdens the socioeconomic system in the form of increased healthcare costs. An aggressive preemptive effort by healthcare professionals, geared to ensure adherence to immunosuppressants in KTRs, is significant and imperative. METHODS/DESIGN: This study was designed as a prospective, open-label, multicenter, randomized controlled study aimed at evaluating the efficacy and stability of an information and communication technology (ICT)-based centralized monitoring system in boosting medication adherence in KTRs. One hundred fourteen KTRs registered throughout the year 2017 to 2018 are randomized into either the ICT-based centralized home monitoring system or to ambulatory follow-up. The planned follow-up duration is 6 months. The ICT-based centralized home monitoring system described consists of a smart pill box equipped with personal identification system, a home monitoring system, an electronic Case Report Form (eCRF) system, and a comprehensive clinical trial management system (CTMS). It alerts both patients and medical staff with texts and pill box alarms if there is a dosage/dosing time error or a missed dose. Medication adherence and transplant outcomes for the follow-up period are compared between the two groups, while patient satisfaction as well as the stability and cost-effectiveness of the ICT-based monitoring system are to be evaluated. DISCUSSION: This on-going study is expected to determine if consistent use of the ICT-based centralized monitoring system described could maximize mediation adherence and subsequently enhance transplant outcomes in KTRs. Further, it would lay the foundation for successful implementation of this ICT-based monitoring system for effective management of medication adherence in KTRs. TRIALS REGISTRATION: ClinicalTrials.gov, Identifier: NCT03136588. Registered on 20 April 2017. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13063-017-2221-z) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5644178 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-56441782017-10-26 The efficacy and stability of an information and communication technology-based centralized monitoring system of adherence to immunosuppressive medication in kidney transplant recipients: study protocol for a randomized controlled trial Jung, Hee-Yeon Seong, Sook Jin Choi, Ji-Young Cho, Jang-Hee Park, Sun-Hee Kim, Chan-Duck Yoon, Young-Ran Kim, Hyung-Kee Huh, Seung Yoon, Se-Hee Lee, Jong Soo Kim, Yong-Lim Trials Study Protocol BACKGROUND: Immunosuppression non-adherence in kidney transplant recipients (KTRs) not only increases the risk of medical intervention due to acute rejection and graft loss but burdens the socioeconomic system in the form of increased healthcare costs. An aggressive preemptive effort by healthcare professionals, geared to ensure adherence to immunosuppressants in KTRs, is significant and imperative. METHODS/DESIGN: This study was designed as a prospective, open-label, multicenter, randomized controlled study aimed at evaluating the efficacy and stability of an information and communication technology (ICT)-based centralized monitoring system in boosting medication adherence in KTRs. One hundred fourteen KTRs registered throughout the year 2017 to 2018 are randomized into either the ICT-based centralized home monitoring system or to ambulatory follow-up. The planned follow-up duration is 6 months. The ICT-based centralized home monitoring system described consists of a smart pill box equipped with personal identification system, a home monitoring system, an electronic Case Report Form (eCRF) system, and a comprehensive clinical trial management system (CTMS). It alerts both patients and medical staff with texts and pill box alarms if there is a dosage/dosing time error or a missed dose. Medication adherence and transplant outcomes for the follow-up period are compared between the two groups, while patient satisfaction as well as the stability and cost-effectiveness of the ICT-based monitoring system are to be evaluated. DISCUSSION: This on-going study is expected to determine if consistent use of the ICT-based centralized monitoring system described could maximize mediation adherence and subsequently enhance transplant outcomes in KTRs. Further, it would lay the foundation for successful implementation of this ICT-based monitoring system for effective management of medication adherence in KTRs. TRIALS REGISTRATION: ClinicalTrials.gov, Identifier: NCT03136588. Registered on 20 April 2017. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13063-017-2221-z) contains supplementary material, which is available to authorized users. BioMed Central 2017-10-16 /pmc/articles/PMC5644178/ /pubmed/29037222 http://dx.doi.org/10.1186/s13063-017-2221-z Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Study Protocol Jung, Hee-Yeon Seong, Sook Jin Choi, Ji-Young Cho, Jang-Hee Park, Sun-Hee Kim, Chan-Duck Yoon, Young-Ran Kim, Hyung-Kee Huh, Seung Yoon, Se-Hee Lee, Jong Soo Kim, Yong-Lim The efficacy and stability of an information and communication technology-based centralized monitoring system of adherence to immunosuppressive medication in kidney transplant recipients: study protocol for a randomized controlled trial |
title | The efficacy and stability of an information and communication technology-based centralized monitoring system of adherence to immunosuppressive medication in kidney transplant recipients: study protocol for a randomized controlled trial |
title_full | The efficacy and stability of an information and communication technology-based centralized monitoring system of adherence to immunosuppressive medication in kidney transplant recipients: study protocol for a randomized controlled trial |
title_fullStr | The efficacy and stability of an information and communication technology-based centralized monitoring system of adherence to immunosuppressive medication in kidney transplant recipients: study protocol for a randomized controlled trial |
title_full_unstemmed | The efficacy and stability of an information and communication technology-based centralized monitoring system of adherence to immunosuppressive medication in kidney transplant recipients: study protocol for a randomized controlled trial |
title_short | The efficacy and stability of an information and communication technology-based centralized monitoring system of adherence to immunosuppressive medication in kidney transplant recipients: study protocol for a randomized controlled trial |
title_sort | efficacy and stability of an information and communication technology-based centralized monitoring system of adherence to immunosuppressive medication in kidney transplant recipients: study protocol for a randomized controlled trial |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644178/ https://www.ncbi.nlm.nih.gov/pubmed/29037222 http://dx.doi.org/10.1186/s13063-017-2221-z |
work_keys_str_mv | AT jungheeyeon theefficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial AT seongsookjin theefficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial AT choijiyoung theefficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial AT chojanghee theefficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial AT parksunhee theefficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial AT kimchanduck theefficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial AT yoonyoungran theefficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial AT kimhyungkee theefficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial AT huhseung theefficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial AT yoonsehee theefficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial AT leejongsoo theefficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial AT kimyonglim theefficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial AT jungheeyeon efficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial AT seongsookjin efficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial AT choijiyoung efficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial AT chojanghee efficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial AT parksunhee efficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial AT kimchanduck efficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial AT yoonyoungran efficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial AT kimhyungkee efficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial AT huhseung efficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial AT yoonsehee efficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial AT leejongsoo efficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial AT kimyonglim efficacyandstabilityofaninformationandcommunicationtechnologybasedcentralizedmonitoringsystemofadherencetoimmunosuppressivemedicationinkidneytransplantrecipientsstudyprotocolforarandomizedcontrolledtrial |